PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
53.64%
Revenue growth at 50-75% of PGN.DE's 85.35%. Martin Whitman would worry about competitiveness or product relevance.
-168.68%
Negative gross profit growth while PGN.DE is at 69.09%. Joel Greenblatt would examine cost competitiveness or demand decline.
-7.40%
Negative EBIT growth while PGN.DE is at 164.12%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-7.39%
Negative operating income growth while PGN.DE is at 232.85%. Joel Greenblatt would press for urgent turnaround measures.
-8.95%
Negative net income growth while PGN.DE stands at 225.37%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.00%
Share change of 10.00% while PGN.DE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
10.00%
Diluted share change of 10.00% while PGN.DE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
745.08%
10Y revenue/share CAGR above 1.5x PGN.DE's 334.67%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
913.34%
5Y revenue/share CAGR above 1.5x PGN.DE's 250.77%. David Dodd would look for consistent product or market expansions fueling outperformance.
185.69%
3Y revenue/share CAGR 1.25-1.5x PGN.DE's 160.45%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
308.88%
Positive OCF/share growth while PGN.DE is negative. John Neff might see a comparative advantage in operational cash viability.
74.90%
Positive 3Y OCF/share CAGR while PGN.DE is negative. John Neff might see a big short-term edge in operational efficiency.
-580.12%
Negative 10Y net income/share CAGR while PGN.DE is at 136.77%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-3303.26%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-743.20%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
2563.80%
5Y equity/share CAGR above 1.5x PGN.DE's 629.25%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
187.23%
Below 50% of PGN.DE's 497.36%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
123.45%
AR growth well above PGN.DE's 61.36%. Michael Burry fears inflated revenue or higher default risk in the near future.
89.51%
Inventory growth well above PGN.DE's 22.63%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.77%
Asset growth at 50-75% of PGN.DE's 9.45%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
-28.44%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
67.81%
Debt growth far above PGN.DE's 15.77%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-11.07%
We cut SG&A while PGN.DE invests at 33.59%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.
1.14 - 1.17
1.10 - 1.60
14.0K / 2.1K (Avg.)
-9.00 | -0.13